Pharmaceutical composition for treating hyperthyreosis

A technology for thyroid function and composition, which can be used in drug combinations, pharmaceutical formulations, plant raw materials, etc., and can solve problems such as poor drug efficacy

Inactive Publication Date: 2016-02-17
韩昕健 +1
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The present invention aims at the technical defects of the prior art, and provides a pharmaceutical composition for the treatment of hyperthyroidism, so as to solve the technical problem of the poor curative effect of the hyperthyroidism treatment drugs of the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating hyperthyreosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] A pharmaceutical composition for treating hyperthyroidism, which consists of the following ingredients in parts by weight: 8 parts of squeezed juice from ginkgo biloba leaves, 4 parts of squeezed juice from dogwood, 2 parts of squeezed rose juice, 1 part of squeezed juice from goosegrass, and 1 part of squeezed juice from Qianjinzi 1 part of mulberry juice, 1 part of pressed camellia juice, 1 part of pressed fern juice, 1 part of pressed honeysuckle juice, 1 part of pressed cucumber juice.

Embodiment 2

[0023] A pharmaceutical composition for treating hyperthyroidism, which consists of the following ingredients in parts by weight: 10 parts of squeezed juice from ginkgo biloba leaves, 6 parts of squeezed juice from dogwood, 3 parts of squeezed rose juice, 2 parts of squeezed juice from goosegrass, and 2 parts of squeezed juice from Qianjinzi 2 parts of mulberry juice, 2 parts of mulberry juice, 2 parts of camellia juice, 2 parts of fern juice, 2 parts of honeysuckle juice, and 2 parts of cucumber juice.

Embodiment 3

[0025] A pharmaceutical composition for treating hyperthyroidism, which consists of the following components by weight: 9 parts of squeezed juice from ginkgo biloba leaves, 5 parts of squeezed juice from dogwood, 2.3 parts of squeezed rose juice, 1.8 parts of squeezed juice from goosegrass, and 1.8 parts from squeezed 1.5 parts of mulberry juice, 1.6 parts of pressed mulberry juice, 1.7 parts of pressed camellia juice, 1.8 parts of pressed fern juice, 1.2 parts of pressed honeysuckle juice, and 1.8 parts of pressed cucumber juice.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutical composition for treating hyperthyreosis. Ginkgo leaf tablets and fructus corni serve as main components, roses, eleusine indica, moleplant seeds, mulberries, camellia japonica, Chinese brake herbs, honeysuckle flowers and cucumbers are matched simultaneously, and the composition is prepared. According to an existing medical cognitive level, the components do not have direct promoting action on conditioning of an endocrine system or treatment of the hyperthyreosis; according to accident discoveries through experimental measures, the components are combined, the pharmaceutical composition which is obtained after optimization design is conducted on dosages of all the components can effectively treat the hyperthyreosis, the effect is taken rapidly, and the adverse reaction does not exist. On the basis of the positive discoveries, the pharmaceutical composition is obtained by an applicant; prominent technical effects are obtained through exquisite material selection and reasonable dosage design; meanwhile, the pharmaceutical composition is low in cost and easy to achieve, and the prominent popularizing prospect is achieved.

Description

technical field [0001] The invention relates to the technical field of endocrine disease treatment, in particular to a pharmaceutical composition for treating hyperthyroidism. Background technique [0002] Hyperthyroidism, referred to as "hyperthyroidism", is a disease in which the thyroid gland synthesizes and releases excessive thyroid hormones, causing hypermetabolism and sympathetic nerve excitement, causing palpitations, sweating, increased eating and stool frequency, and weight loss. Most patients also often have exophthalmos, eyelid edema, vision loss and other symptoms at the same time. [0003] In the prior art, there are mainly three methods for the treatment of hyperthyroidism, namely antithyroid drug treatment, radioactive iodine treatment and surgical treatment. Among them, both radioactive iodine therapy and surgical treatment are destructive treatments, and their advantage is that if the treatment is successful, it is not easy to relapse. However, since the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/82A61P5/16
Inventor 韩昕健孙秀燕
Owner 韩昕健
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap